Shotar, Eimad http://orcid.org/0000-0002-8712-8431
Barberis, Eric
Chougar, Lydia
Bensoussan, Sacha
Parat, Damien
Ghannouchi, Haroun
Premat, Kevin
Lenck, Stephanie
Degos, Vincent
Lehericy, Stéphane
Sourour, Nader-Antoine
Mathon, Bertrand
Clarençon, Frédéric
Article History
Received: 6 January 2022
Accepted: 13 June 2022
First Online: 7 July 2022
Declarations
:
: The authors of this manuscript declare relationships with the following companies: F. Clarençon reports conflict of interest (unrelated) with Medtronic, Guerbet, Balt Extrusion (payment for readings), Codman Neurovascular (core laboratory). N.-A. Sourour is consultant for Medtronic, Balt Extrusion, Microvention. E. Shotar is principal investigator of a randomized controlled trial related to CSDH embolization financed by a PHRC-IR public grant (unrelated to the present study). E. Barberis, L. Chougar, S. Bensoussan, D. Parat, H. Ghannouchi, K. Premat, S. Lenck, V. Degos, S. Lehericy and B. Mathon declare that they have no competing interests.
: The institutional review board approved this study (CERIM IRB CRM-2003-063). The need for signed patient consent was waived.